Linkedin
Sign in
Join
Thought Leadership
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Thursday, May 29, 2025
25.8
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Interview with Salil Kallianpur
0
MedicinMan announces workshops on Digital Marketing in Pharma and Sales Force Excellence.
Indian Pharma Market (IPM) Highlights – January 2025
0
Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...
Great Opportunity for Pharma People to Listen to What Doctors have to Say
0
An insightful and informative Q&A session with Dr. Tejal...
An Infectious Disease Specialist Speaks to Pharma on How it Needs to Change its Approach
0
Key Point from the Q &A with Dr. Mandar...
Raja Reddy – 7 Thinking Patterns that Shaped My Career
0
Raja Reddy is presently the head of marketing at Servier...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Marketing
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Policies/Sales
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Strategy
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Subscribe
Thought Leadership
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
7 Ways to Increase Productivity of Pharma Sales Reps
0
With access to HCPs becoming a daunting task for...
How will the Indian Pharma Market Shape Up?
0
While there is a big buzz around digital adoption...
5 L&D Megatrends
0
2017 Learning and Development Special Issue. Articles by K. Hariram, Diksha Fouzdar and Vivek Hattangadi.
Are Managers Really Necessary?
0
In the organisational context, LEADERSHIP appears more glamorous than...
IMS Health Market Reflection Report for August 2016
0
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,426 crores in the month of August 2016 clocking a strong 18% growth over same period last year (SPLY). This was the second consecutive month where the IPM crossed the 10,000 crore mark.
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Marketing
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Policies/Sales
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Strategy
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
0
Tata 1mg App Business Model: How does it work...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
Indian Pharma Market Performance – April 2025
0
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
The Future in Your Palm+Chemistry – Palmistry
0
The future in your palm - a non-contact wearable...
Subscribe
Featured Article
AI in Healthcare
Digital in Pharma
Exclusive Articles
IMS Monthly Market Reflection Report
Indian Pharma Market Reports
Leaderspeak
Medical Devices
Press Release
Featured Article
Novo Nordisk — Septerna’s $2.2 Billion Deal
Anup Soans
-
May 16, 2025
Read More
AI in Healthcare
The Future in Your Palm+Chemistry – Palmistry
Anup Soans
-
May 3, 2025
Read More
Exclusive Articles
Nimesulide – Nice or Not Nise?
Anup Soans
-
May 2, 2025
Read More
AI in Healthcare
MedicinMan Pharma Monitor March 2025
Anup Soans
-
April 14, 2025
Read More
Featured Article
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
Anup Soans
-
April 14, 2025
Read More
Featured Article
Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends
Anup Soans
-
April 12, 2025
Read More
Load more